
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol. , 03 January 2022
Sec. Cardiovascular and Smooth Muscle Pharmacology
Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.827490
This article is a correction to:
9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
A Corrigendum on
9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice
by Wang, Y.-M., Mi, S.-L., Jin, H., Guo, Q.-L., Yu, Z.-Y., Wang, J.-T., Zhang, X.-M., Zhang, Q., Wang, N.-N., Huang, Y.-Y., Zhou, H.-G., and Guo, J.-C. (2021). Front. Pharmacol. 12:754387. doi: 10.3389/fphar.2021.754387
In the published article, there was an error in affiliation 1 and 4. Instead of “1Department of Geriatrics of Huashan Hospital, National Clinical Research Center for Aging and Medicine, Fudan University, Shanghai, China” and “4Department of Translational Neuroscience, Jing’an District Centre Hospital of Shanghai and State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China,” it should be 1Department of Geriatrics of Huashan Hospital, National Clinical Research Center for Aging and Medicine, Department of Translational Neuroscience, Jing’an District Centre Hospital of Shanghai, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: diabetic cardiovascular complications, autophagy, 9-PAHSA, myocardial hypertrophy, vascular calcification
Citation: Wang Y-M, Mi S-L, Jin H, Guo Q-L, Yu Z-Y, Wang J-T, Zhang X-M, Zhang Q, Wang N-N, Huang Y-Y, Zhou H-G and Guo J-C (2022) Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice. Front. Pharmacol. 12:827490. doi: 10.3389/fphar.2021.827490
Received: 02 December 2021; Accepted: 08 December 2021;
Published: 03 January 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Wang, Mi, Jin, Guo, Yu, Wang, Zhang, Zhang, Wang, Huang, Zhou and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hou-Guang Zhou, emhvdWhvdWd1YW5nQGh1YXNoYW4ub3JnLmNu; Jing-Chun Guo, amluZ2NodW5ndW9Ac2htdS5lZHUuY24=; Yan-Yan Huang, aHlpd2VuOTRAaG90bWFpbC5jb20=
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.